Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents
New England Journal of Medicine · 12.02.2026 · 394 (7) · 658-668
DOI: 10.1056/nejmoa2512091 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 12.02.2026. Verfasst von Seung-Jun Lee und 50 weiteren Autor:innen. Beteiligte Einrichtung: Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Drug-Eluting Stents, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Samjin Pharmaceutical, Cardiovascular Research Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
- Kosin University Gospel Hospital, Busan, South Korea.
- Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea.
- Ewha Womans University Seoul Hospital, Seoul, South Korea.
- Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.
- Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, South Korea.
ORCID-Profile: Sung Gyun Ahn, Joon-Hyung Doh, Sang-Ho Jo, Chul-Min Ahn, Boyoung Joung, Jung-Sun Kim
Förderung
- Samjin Pharmaceutical
- Cardiovascular Research Center
Zitieren
APA
Lee, S. J., Yu, H. T., Lee, Y. J., Lee, S. H., Heo, J. H., Ahn, S. G., Shin, S., Doh, J. H., Her, A. Y., Cho, B. R., Kim, G. S., Kwon, T. G., Lim, S. W., Shim, J., Jang, J. Y., Lee, K., Cho, Y. H., Choi, C. U., Lee, S. R., …, & ADAPT AF-DES Investigators (2026). Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents. New England Journal of Medicine, 394(7), 658-668. https://doi.org/10.1056/nejmoa2512091
Vancouver
Lee SJ, Yu HT, Lee YJ, Lee SH, Heo JH, Ahn SG, et al. Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents. New England Journal of Medicine. 2026;394(7):658-668. doi:10.1056/nejmoa2512091
BibTeX
@article{Lee2026,
author = {Lee, Seung-Jun and Yu, Hee Tae and Lee, Yong-Joon and Lee, Sang-Hyup and Heo, Jung Ho and Ahn, Sung Gyun and Shin, Sanghoon and Doh, Joon-Hyung and Her, Ae-Young and Cho, Byung-Ryul and Kim, Gwang-Sil and Kwon, Taek-Geun and Lim, Sang-Wook and Shim, Jaemin and Jang, Ji-Yong and Lee, Kyounghoon and Cho, Yun-Hyeong and Choi, Cheol Ung and Lee, Sang-Rok and Park, Hyung-Bok and Lee, Han Cheol and Kim, Seunghwan and Yun, Kyeong Ho and Ahn, Jong-Hwa and Lee, Byoung-Kwon and Cho, Deok-Kyu and Kim, Song-Yi and Kim, Ung and Kang, Tae Soo and Choi, Seong Huan and Kim, Won-Ho and Lee, Jin Bae and Rhee, Moo-Yong and Kim, Jin-Bae and Jo, Sang-Ho and Hyun, Dae Woo and Kim, Daehoon and Kim, Tae-Hoon and Hong, Sung-Jin and Uhm, Jae-Sun and Shin, Dong-Ho and Ahn, Chul-Min and Kim, Byeong-Keuk and Joung, Boyoung and Ko, Young-Guk and Choi, Donghoon and Hong, Myeong-Ki and Jang, Yangsoo and Pak, Hui-Nam and Kim, Jung-Sun and ADAPT AF-DES Investigators, ADAPT AF-DES Investigators},
title = {Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {7},
pages = {658--668},
doi = {10.1056/nejmoa2512091}
}
EUVIMED